Article
Single-nucleotide polymorphism in the promoter region of the osteopontin gene at nucleotide -443 as a marker predicting the efficacy of pegylated interferon/ribavirin-therapy in Egyptians patients with chronic hepatitis C.
Human immunology - 1 Oct 2012
Shaker Olfat Gamil, Sadik Nermin A H, El-Dessouki Abeer
Abstract excerpt
Osteopontin (OPN) is an extracellular matrix glycophosphoprotein produced by several types of cells including the immune system. The present study examined the possibility that single-nucleotide polymorphisms (SNP) in the promoter region of the OPN at nt -443 is a marker predicting the therapeutic efficacy of pegylated interferon (peg-IFN-α2b)-ribavirin combination therapy in Egyptian patients with chronic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.